Great ann. I topped up a bit today.
I love investing in Biotech. I also back Tyler Schilller and Harry Coffee religeously.
Considering what recently happend with OPT does anyone ever consider the potential for failure?
Clearly if you are here you believe the company is on the path to success. But, what does anyone really consider the risk seriously?
Ann: Neuren initiates development of NNZ-2591 to treat HIE, page-39
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.56 |
Change
0.550(3.23%) |
Mkt cap ! $2.222B | |||
| Open | High | Low | Value | Volume |
| $17.48 | $18.44 | $17.48 | $10.68M | 595.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 171 | $17.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.58 | 406 | 4 |
View Market Depth
| Last trade - 13.21pm 07/08/2025 (20 minute delay) ? |
| NEU (ASX) Chart |